Překvapivé nikotinové touhy jsou úspěšně uvolněny milcovny Niquitin a jejich účinky vydrží i poté, co byly spotřebovány. Když jsou pravidelně používány, dávají vašemu tělovému terapeutickému nikotinu a pomáhají vám při snižování počtu cigaret, které kouříte nebo zcela ukončíte.

Vezměte si pašinky Niquitin, pokud touha náhle udeřte. Pastivé pastilky s mincovnou poskytují úlevu od touhy v cigaretách a abstinenčních příznaků snížením vaší potřeby nikotinu.

Pokud jste během svého programu léčby Niquitin Lozenge kouřili jednu nebo dvě cigarety, ale přesto si přejete přestat, můžete Lozenge nadále přijímat jako obvykle. Pokud jste pokračovali v kouření, nastavte nové datum ukončení a zkuste to znovu, až budete připraveni. Nebo, pokud se zastavení okamžitě jeví jako příliš velký krok pro vás, použijte Lozenges, abyste vám pomohli omezit, kolik cigaret kouříte, než se vzdáte úplně.

Varování:
• Používejte pouze tehdy, pokud máte nejméně 12 let a nejste kuřák nebo kouří jen občas.
• Nenechávejte věci nad 25 stupňů
• Neužívejte více než 15 pastingů denně.
• Při žvýkání nikdy nepolypujte.

Tyto zobrazené obrázky produktu mohou představovat rozsah produktů nebo být pouze pro ilustrační účely a nemusí být přesným reprezentací produktu.

Welzo is not liable for discrepancies on the website. Check product packaging for exact information.

• GTIN: 5012616264382
• Manufacturer: Niquitin
• Size: 2mg / 72 pastilek
• Categories: Nicotinové záplatyNikotinové pastilkyNiquitinPřes pult produkty
• Best buy: 6 - 24 months+

United Kingdom & Rest of the World Shipping Details:
Same day dispatch for orders placed by 2pm (Orders after 2pm dispatched next working day).

Free shipping on orders over £50 to the UK.

Returns: Our products are meant to make you feel healthy and at your best. If you need to return your item, you can do so free of charge within 30 days in the same original and unopened packaging. Subject to T&C's.

Usage Instructions: NiQuitin 4 mg Mint or Original Lozenges are intended for smokers who have their first cigarette within 30 minutes of waking. NiQuitin 2 mg Mint or Original Lozenges are for those who smoke their first cigarette after 30 minutes of waking. Place one lozenge in the mouth and let it dissolve, moving it occasionally from one side to the other until fully dissolved (about 20-30 minutes). Do not chew or swallow the lozenge whole. Avoid eating or drinking while the lozenge is in the mouth. Behavioral therapy, advice, and support can enhance success rates.

Adults (18+): Aim to quit smoking entirely while using NiQuitin Mint or Original Lozenges.

Recommended Treatment Plan:
- Step 1 (Weeks 1-6): 1 lozenge every 1-2 hours
- Step 2 (Weeks 7-9): 1 lozenge every 2-4 hours
- Step 3 (Weeks 10-12): 1 lozenge every 4-8 hours

During weeks 1-6, use at least 9 lozenges daily, not exceeding 15 per day. To maintain a smoke-free status after 12 weeks, use 1-2 lozenges per day only when strongly tempted to smoke. If using lozenges beyond 9 months, seek additional guidance from a healthcare professional.

KEEP ALL MEDICINES OUT OF REACH AND SIGHT OF CHILDREN. READ ALL PRODUCT PACKAGING AND LABELS BEFORE USE.

Welzo is not liable for allergen information. Always follow the directions/ingredients on the product packaging to ensure proper use.

The risks of using Nicotine Replacement Therapy (NRT) are generally much lower than the dangers of continued smoking. Patients hospitalized for heart attack, severe heart rhythm issues, or stroke who are not stable should try to quit smoking using non-drug methods. If these methods fail, NiQuitin Mint or Original Lozenges may be considered, but due to limited safety data for this group, they should only be started under medical supervision. After hospital discharge, patients can use NRT as usual.

Diabetes Mellitus: Patients with diabetes should closely monitor blood sugar levels when starting NRT, as nicotine can affect carbohydrate metabolism.

Allergic reactions: Risk of angioedema and hives.

A healthcare professional should assess risks and benefits for patients with the following conditions:

Renal and hepatic impairment: Use cautiously in patients with moderate to severe liver or severe kidney impairment, as nicotine clearance may be reduced, increasing adverse effects.

Phaeochromocytoma and uncontrolled hyperthyroidism: Use cautiously as nicotine can release catecholamines.

GI disease: Swallowed nicotine may worsen symptoms in patients with esophagitis, gastric or peptic ulcers. Use oral NRT preparations cautiously. Ulcerative stomatitis has been reported.

Danger in small children: Nicotine doses tolerated by adults and adolescents can be highly toxic and potentially fatal to small children. Keep nicotine products out of children's reach.

Stopping smoking: Quitting smoking may slow the metabolism of certain drugs, leading to increased blood levels.

Transferred dependence: Rare and less harmful than smoking dependence.

Phenylketonuria: NiQuitin Mint or Original Lozenges contain phenylalanine, which may be harmful to people with phenylketonuria.

Sodium content: Each lozenge contains 15 mg of sodium. Consider this for low-sodium diets.

KEEP ALL MEDICINES OUT OF REACH AND SIGHT OF CHILDREN. READ ALL PRODUCT PACKAGING AND LABELS BEFORE USE.